Crinetics Pharmaceuticals has filed a notice of an exempt offering of securities to raise $350,000,028.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Crinetics Pharmaceuticals is raising up to $350,000,028.00 in new funding. Sources indicate that as part of senior management Chief Financial Officer, Marc Wilson played a…